194 related articles for article (PubMed ID: 15572377)
1. Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells.
Hendriks BS; Orr G; Wells A; Wiley HS; Lauffenburger DA
J Biol Chem; 2005 Feb; 280(7):6157-69. PubMed ID: 15572377
[TBL] [Abstract][Full Text] [Related]
2. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels.
Hendriks BS; Opresko LK; Wiley HS; Lauffenburger D
J Biol Chem; 2003 Jun; 278(26):23343-51. PubMed ID: 12686539
[TBL] [Abstract][Full Text] [Related]
4. HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells.
Zhang Y; Opresko L; Shankaran H; Chrisler WB; Wiley HS; Resat H
BMC Cell Biol; 2009 Oct; 10():78. PubMed ID: 19878579
[TBL] [Abstract][Full Text] [Related]
5. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
Li X; Huang Y; Jiang J; Frank SJ
Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
[TBL] [Abstract][Full Text] [Related]
6. Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3.
Shankaran H; Zhang Y; Tan Y; Resat H
PLoS Comput Biol; 2013; 9(8):e1003201. PubMed ID: 23990774
[TBL] [Abstract][Full Text] [Related]
7. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects.
Hendriks BS; Opresko LK; Wiley HS; Lauffenburger D
Cancer Res; 2003 Mar; 63(5):1130-7. PubMed ID: 12615732
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells.
Ruschel A; Ullrich A
Cell Signal; 2004 Nov; 16(11):1249-61. PubMed ID: 15337524
[TBL] [Abstract][Full Text] [Related]
9. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
10. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.
Zhou H; Kim YS; Peletier A; McCall W; Earp HS; Sartor CI
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):344-52. PubMed ID: 14751502
[TBL] [Abstract][Full Text] [Related]
11. External and internal EGFR-activating signals drive mammary epithelial cells proliferation and viability.
Morato A; Martignani E; Miretti S; Baratta M; Accornero P
Mol Cell Endocrinol; 2021 Jan; 520():111081. PubMed ID: 33181234
[TBL] [Abstract][Full Text] [Related]
12. MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701.
Chen CH; Hsia TC; Yeh MH; Chen TW; Chen YJ; Chen JT; Wei YL; Tu CY; Huang WC
Mol Oncol; 2017 Sep; 11(9):1273-1287. PubMed ID: 28632938
[TBL] [Abstract][Full Text] [Related]
13. Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.
Spivak-Kroizman T; Rotin D; Pinchasi D; Ullrich A; Schlessinger J; Lax I
J Biol Chem; 1992 Apr; 267(12):8056-63. PubMed ID: 1349015
[TBL] [Abstract][Full Text] [Related]
14. Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation.
Patel D; Bassi R; Hooper A; Prewett M; Hicklin DJ; Kang X
Int J Oncol; 2009 Jan; 34(1):25-32. PubMed ID: 19082474
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the effects of co-expressing EGFR and HER2 on HER activation and trafficking.
Shankaran H; Zhang Y; Opresko L; Resat H
Biochem Biophys Res Commun; 2008 Jun; 371(2):220-4. PubMed ID: 18424261
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics.
Kiyatkin A; van Alderwerelt van Rosenburgh IK; Klein DE; Lemmon MA
Sci Signal; 2020 Aug; 13(645):. PubMed ID: 32817373
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
18. ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.
Worthylake R; Opresko LK; Wiley HS
J Biol Chem; 1999 Mar; 274(13):8865-74. PubMed ID: 10085130
[TBL] [Abstract][Full Text] [Related]
19. Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.
Wang J; Hollingshead J; El-Masry N; Horncastle D; Talbot I; Tomlinson I; Alison MR; El-Bahrawy M
J Gastrointest Cancer; 2012 Sep; 43(3):444-55. PubMed ID: 21989899
[TBL] [Abstract][Full Text] [Related]
20. Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context.
Joslin EJ; Shankaran H; Opresko LK; Bollinger N; Lauffenburger DA; Wiley HS
Mol Biosyst; 2010 Jul; 6(7):1293-306. PubMed ID: 20458382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
